|
⚲
|
| Keyboard |
| Lorrain Daniel S
✚
|
|
|---|---|
| CIK # | 0001861550 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001861550] | |
| 4 | [0001861550] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Contineum Therapeutics Inc | |
| Lorrain Daniel S |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2026-03-02 | Sell | 4,170 | $15.01 | 62,592 |
|
Contineum Therapeutics Inc CTNM
Stock Option (right to buy) · derivative
|
2026-02-25 | Option exercise | 3,824 | $0.00 | |
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2026-02-25 | Sell | 3,824 | $16.01 | 61,222 |
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2026-02-25 | Option exercise | 3,824 | $1.01 | 3,862 |
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2026-02-24 | Sell | 4,300 | $16.03 | 68,929 |
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2026-02-24 | Option exercise | 4,300 | $1.01 | 4,343 |
|
Contineum Therapeutics Inc CTNM
Stock Option (right to buy) · derivative
|
2026-02-24 | Option exercise | 4,300 | $0.00 | |
|
Contineum Therapeutics Inc CTNM
Stock Option (right to buy) · derivative
|
2026-02-19 | Option exercise | 100 | $0.00 | |
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2026-02-19 | Option exercise | 100 | $1.01 | 101 |
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2026-02-19 | Sell | 100 | $16.00 | 1,600 |
|
Contineum Therapeutics Inc CTNM
Stock Option (right to buy) · derivative
|
2026-02-11 | Option exercise | 400 | $0.00 | |
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2026-02-11 | Option exercise | 400 | $1.01 | 404 |
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2026-02-11 | Sell | 400 | $16.00 | 6,400 |
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2026-02-03 | Sell | 1,170 | $15.25 | 17,842 |
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2026-02-03 | Sell | 3,000 | $14.82 | 44,460 |
|
Contineum Therapeutics Inc CTNM
Stock Option (right to buy) · derivative
|
2026-01-30 | Grant | 6,500 | $0.00 | |
|
Contineum Therapeutics Inc CTNM
Stock Option (right to buy) · derivative
|
2026-01-30 | Grant | 160,000 | $0.00 | |
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2026-01-05 | Sell | 500 | $11.13 | 5,565 |
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2026-01-05 | Sell | 3,670 | $10.35 | 37,984 |
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2025-12-23 | Sell | 4,170 | $12.23 | 50,999 |
| showing 20 of 27 most recent transactions | |||||